| Product NDC: | 60977-144 |
| Proprietary Name: | Dopram |
| Non Proprietary Name: | DOXAPRAM HYDROCHLORIDE |
| Active Ingredient(s): | 20 mg/mL & nbsp; DOXAPRAM HYDROCHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60977-144 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA014879 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101129 |
| Package NDC: | 60977-144-02 |
| Package Description: | 6 BOX in 1 CARTON (60977-144-02) > 1 VIAL, MULTI-DOSE in 1 BOX (60977-144-01) > 20 mL in 1 VIAL, MULTI-DOSE (60977-144-63) |
| NDC Code | 60977-144-02 |
| Proprietary Name | Dopram |
| Package Description | 6 BOX in 1 CARTON (60977-144-02) > 1 VIAL, MULTI-DOSE in 1 BOX (60977-144-01) > 20 mL in 1 VIAL, MULTI-DOSE (60977-144-63) |
| Product NDC | 60977-144 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOXAPRAM HYDROCHLORIDE |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20101129 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | DOXAPRAM HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Increased Medullary Respiratory Drive [PE],Respiratory Stimulant [EPC] |